ANTIDOTE TECHNOLOGIES INC.
NORTH MIAMI BEACH, FLORIDA

We're speeding up the development of breakthrough treatments by making medical research accessible and transparent for all. Our Mission Antidote is a digital health company on a mission. Our aim is to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of awareness, we use cutting-edge technology to match the right patients with the right trials. We’re helping medical researchers make progress, faster – and offering new treatment options to patients in need. This is a global effort to advance healthcare for everyone. If you are a patient or you know someone who is, you can help simply by searching for studies that matter to you. If you are a researcher, talk to us to find out how we can help you connect with patients who may be interested in your work. is a clinical trial search platform that helps patients easily find studies right for them. These solutions help research teams, pharmaceutical companies, and other organizations complete their studies faster. Francesca Domenech Wuttke, Ph.D. is a Managing Director focused on identifying new investment opportunities in Europe for the Merck Global Health Innovation Fund, LLC. Dr. Wuttke brings with her broad drug development and healthcare expertise in both the US and Europe, with over 20 years of clinical, commercial, strategic and transactional experience. She has worked with diverse organizations including start-ups, consulting, large and specialty pharma as well as academia. Most recently Dr. Wuttke led Almirall´s Corporate Development Strategy team to transact on both med device and pharma M&A opportunities with a new and targeted focus for the company. Before that Dr. Wuttke worked at Novartis where she was responsible for two Cell and Gene therapy opportunities that were successfully brought into the organization as well as managing the strategy and commercialization for the existing portfolio of cell therapy assets. Dr. Wuttke holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences. Aarti is a Senior Associate at Smedvig Capital, which she joined in 2013. Prior to Smedvig Capital, Aarti started her career in Investment Banking at Merrill Lynch and then moved to Bain & Company where she worked on strategic projects for FTSE 100 clients and leading private equity funds. Aarti spends most of her time focussing on Smedvig Capital’s portfolio, helping management teams to further grow their businesses and supporting them in driving and implementing strategic and operational initiatives. Aarti is currently an advisor to Kings Court Trust, The Smart Cube, Antidote and Quill, and has previously worked with Captify. Company outings Interested? We are hiring! We’re looking for smart, dynamic folks who share in our mission of advancing medical research. We ensure our employees have what they need to be successful in the business. This includes managing the company's finances, people, and talent. We educate people about Antidote through thought leadership and grassroots movements. We're collaborating with patient advocates on a global effort. Business Development Team We partner with clients to understand their needs and how our unique solutions can help advance their clinical development program. Product Team We translate our vision to empower patients and doctors into products and features that improves our user's experience. We're focused on speeding up research for our clients. We work with clients, patients, sites and internal teams to connect the right patients to the right trials. Interested? We are hiring! We’re looking for smart, dynamic folks who share in our mission of advancing medical research. Sound like you? We're speeding up the development of breakthrough treatments by making medical research accessible and transparent for all. Our Mission Antidote is a digital health company on a mission. Our aim is to accelerate breakthroughs in potentially life-saving treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of awareness, we use cutting-edge technology to match the right patients with the right trials. We’re helping medical researchers make progress, faster – and offering new treatment options to patients in need. This is a global effort to advance healthcare for everyone. If you are a patient or you know someone who is, you can help simply by searching for studies that matter to you. If you are a researcher, talk to us to find out how we can help you connect with patients who may be interested in your work. is a clinical trial search platform that helps patients easily find studies right for them. These solutions help research teams, pharmaceutical companies, and other organizations complete their studies faster. Francesca Domenech Wuttke, Ph.D. is a Managing Director focused on identifying new investment opportunities in Europe for the Merck Global Health Innovation Fund, LLC. Dr. Wuttke brings with her broad drug development and healthcare expertise in both the US and Europe, with over 20 years of clinical, commercial, strategic and transactional experience. She has worked with diverse organizations including start-ups, consulting, large and specialty pharma as well as academia. Most recently Dr. Wuttke led Almirall´s Corporate Development Strategy team to transact on both med device and pharma M&A opportunities with a new and targeted focus for the company. Before that Dr. Wuttke worked at Novartis where she was responsible for two Cell and Gene therapy opportunities that were successfully brought into the organization as well as managing the strategy and commercialization for the existing portfolio of cell therapy assets. Dr. Wuttke holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences.